Portfolio company
Red Queen Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops AI-powered antibody drugs and medical countermeasures against biological threats for governments, biopharma organisations and frontier artificial intelligence laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Valthos
This company develops artificial intelligence systems that identify biological threats and design medical countermeasures for government and life sciences organisations.
Antiverse
This company uses generative AI to design functional antibody biologics for pharmaceutical organisations targeting complex medical conditions and transmembrane proteins.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
Converge Bio
The company develops AI software for antibody design and optimization to assist pharmaceutical firms in drug discovery and development.
Bioqore
The company develops AI-driven bioprocessing models and automated wet lab services to optimise drug manufacturing conditions for biotechnology and pharmaceutical companies.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Aureka Biotechnologies
The company develops artificial intelligence platforms and antibody therapeutics for pharmaceutical and biotechnology organisations to accelerate the discovery and design of medicines.
